Search over 3,000 reports

    Lyrica- Drug Insight, 2017

    Lyrica- Drug Insight, 2017
    Date: Jan, 2018
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0194
    "Lyrica - Drug Insight, 2018" report by DelveInsight provides comprehensive information of the drug, Lyrica. It includes Lyrica`s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Lyrica`s patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.* It also features the historical and forecasted sales of Lyrica till 2020. The report also throws light on Lyrica`s market competition and emerging therapies in the same space as Lyrica. A SWOT analysis of Lyrica is also featured.
    * Depending on information availability

    Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis by DelveInsight’s team of industry experts.
    Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

    Scope of the report
    • A comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
    • Patent information around Lyrica in United States (US) and Europe (EU) has been highlighted
    • API manufacturers for Lyrica in United States, Europe, China and India
    • The report contains historical and forecasted sales for Lyrica till 2020
    • Comprehensive coverage of the emerging therapies (Phase III) in the space where Lyrica operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
    • The report also features the SWOT analysis of Lyrica

    Reasons to Buy
    • Establish a comprehensive understanding of the drug, Lyrica
    • Access to Lyrica`s API manufacturers details to devise API procurement strategy for generic development
    • Plan developmental timelines around Lyrica`s patents for the major markets- US and EU
    • Understand Lyrica`s current and future growth through its historical and forecasted sales
    • Identify and understand the current in-market competitors for Lyrica
    • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
    • Identify and plan ahead for prospective emerging players and their products operating in the same space as Lyrica
    • Identify opportunities in the same area as Lyrica with DelveInsight`s SWOT analysis
    1. Report Introduction
    2. Lyrica - Overview
    • Product Description
    • Route of Synthesis
    • Mechanism of Action
    • Pharmacology
    • Pharmacodynamics
    • Pharmacokinetics
    • Adverse Reactions
    • Clinical Trials
    • Regulatory Milestones
    • Product Development Activities
    3. Global API Manufacturers
    • United States
    • Europe
    • China
    • India
    4. Product Details
    • United States
    • Europe
    5. Lyrica Global Sales Assessment
    • Historical Global Sales
    • Forecasted Global Sales
    6. Patent Details
    7. Market Competition
    8. Emerging Therapies
    8.1. Drug name: Company name
    • Product Description
    • Research & Development
    • Product Development Activities
    Other product profiles in the detailed report…..
    9. SWOT Analysis
    Consulting Services
    About DelveInsight
    Contact Us
    Note: Certain sections of the table of contents would vary according to the availability of information
    Table 1: Lyrica, Description
    Table 2: API Manufacturers Region wise
    Table 3: API Manufacturers for United States
    Table 4: API Manufacturers for Europe
    Table 5: API Manufacturers for China
    Table 6: API Manufacturers for India
    Table 7: Lyrica Product Details, United States
    Table 8: Lyrica Product Details, Europe
    Table 9: Lyrica, Historical Global Sales till 2017 (in million USD)
    Table 10: Lyrica, Forecasted Global Sales from 2018-2020 (in million USD)
    Table 11: Patent Details: Lyrica
    Table 12: Lyrica Major Competitors
    Table 13: Emerging Therapies
    Figure 1: Lyrica
    Figure 2: Lyrica, Historical Global Sales till 2017 (in million USD)
    Figure 3: Lyrica, Forecasted Global Sales from 2018-2020 (in million USD)
    Figure 4: Patent Details: Lyrica
    Figure 5: API Manufacturers Region wise

    Lyrica Marketed Drugs Overview

    Lyrica Market Assessment

    Lyrica API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers

    Lyrica US DMF

    Lyrica US Drug Master Files

    Lyrica Active Substance Master File/ EUDMF

    Lyrica Generic players

    Lyrica Patent Expiration

    Lyrica Patent Exclusivity

    Lyrica API Manufacturers

    Lyrica Global Forecasted Sales Figure

    Lyrica API Route of Synthesis

    Lyrica Market sales

    Lyrica SWOT Analysis

    Lyrica Pipeline

    • Single User License
      (20% Off)
    • Site License
      (30% Off)
    • Global License
      (40% Off)

    Contact Us

    +91-11-45689769, +91 9650213330


    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap